176 related articles for article (PubMed ID: 28352185)
1. Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report.
Deng L; Wang Y; Lu W; Liu Q; Wu J; Jin J
Onco Targets Ther; 2017; 10():1521-1525. PubMed ID: 28352185
[TBL] [Abstract][Full Text] [Related]
2. The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature.
Ding L; Li QJ; You KY; Jiang ZM; Yao HR
Medicine (Baltimore); 2016 May; 95(20):e3598. PubMed ID: 27196461
[TBL] [Abstract][Full Text] [Related]
3. Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature review.
Jin M; Cai J; Wang X; Zhang T; Zhao Y
Cancer Biol Ther; 2018; 19(12):1088-1092. PubMed ID: 30110192
[TBL] [Abstract][Full Text] [Related]
4. Use of apatinib combined with pemetrexed for advanced ovarian cancer: A case report.
Sun H; Xiao M; Liu S; Shi R
Medicine (Baltimore); 2018 Jul; 97(27):e11036. PubMed ID: 29979376
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Low-Dose Apatinib in the Treatment of Intrahepatic Biliary Cystadenoma With Recurrence and Malignant Transformation.
Yang Y; Mai W; Chen W; Yang C; Li M; Liu L
Front Oncol; 2021; 11():676092. PubMed ID: 34262864
[TBL] [Abstract][Full Text] [Related]
6. Apatinib treatment in extensive metastatic advanced thymic carcinoma.
He Y; Liu S; E M; Wang C; Shi M; Liu G; Abiyasi N
J Biol Regul Homeost Agents; 2018; 32(3):693-697. PubMed ID: 29921401
[TBL] [Abstract][Full Text] [Related]
7. Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy.
Liu Z; Ou W; Li N; Wang SY
Thorac Cancer; 2018 Oct; 9(10):1285-1290. PubMed ID: 30126078
[TBL] [Abstract][Full Text] [Related]
8. Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.
Wang Y; Bi M; Zhang H; Gao Z; Zhou H; Chang S
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e528-e530. PubMed ID: 28028915
[TBL] [Abstract][Full Text] [Related]
9. Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study.
Lan CY; Wang Y; Xiong Y; Li JD; Shen JX; Li YF; Zheng M; Zhang YN; Feng YL; Liu Q; Huang HQ; Huang X
Lancet Oncol; 2018 Sep; 19(9):1239-1246. PubMed ID: 30082170
[TBL] [Abstract][Full Text] [Related]
10. Apatinib combined with docetaxel as a salvage treatment for metastatic esophageal squamous cancer: a case report.
Liang LJ; Wen YX; Xia YY; Wang L; Fei JY; Jiang XD
Onco Targets Ther; 2018; 11():5821-5826. PubMed ID: 30271164
[TBL] [Abstract][Full Text] [Related]
11. Long-term progression-free survival of apatinib monotherapy for relapsed ovarian cancer: a case report and literature review.
Zhang D; Huang J; Sun Y; Guo Q
Onco Targets Ther; 2019; 12():3635-3644. PubMed ID: 31190866
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II Study.
Ren D; Wang G; Zhang Y; Kan J; Dong Q; Zhao J; Ji F; Li H; Luo Y; Lin M; Li G; Liu Z; Ma X; Guo Q; Zhao F; Shen G; Zhao J
Onco Targets Ther; 2021; 14():4499-4508. PubMed ID: 34434051
[TBL] [Abstract][Full Text] [Related]
13. Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.
Xie L; Xu J; Sun X; Tang X; Yan T; Yang R; Guo W
Oncologist; 2019 Jul; 24(7):e542-e550. PubMed ID: 30559126
[TBL] [Abstract][Full Text] [Related]
14. Apatinib for the treatment of gastric cancer.
Geng R; Li J
Expert Opin Pharmacother; 2015 Jan; 16(1):117-22. PubMed ID: 25420417
[TBL] [Abstract][Full Text] [Related]
15. A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix.
Chen C; Qin S; Li Z; Luo X; Zhang Y; Zhang J; Liu X
Onco Targets Ther; 2019; 12():5805-5811. PubMed ID: 31410025
[TBL] [Abstract][Full Text] [Related]
16. Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review.
Li CM; Liu ZC; Bao YT; Sun XD; Wang LL
World J Gastroenterol; 2017 Nov; 23(41):7478-7488. PubMed ID: 29151702
[TBL] [Abstract][Full Text] [Related]
17. A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer.
Li XF; Tan YN; Cao Y; Xu JH; Zheng S; Yuan Y
Medicine (Baltimore); 2015 Sep; 94(39):e1661. PubMed ID: 26426663
[TBL] [Abstract][Full Text] [Related]
18. A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer.
Wu F; Zhang S; Xiong A; Gao G; Li W; Cai W; Su C; Chen X; Zhou F; Zhao J; Ren S; Zhou C
Clin Lung Cancer; 2018 Nov; 19(6):e831-e842. PubMed ID: 30026059
[TBL] [Abstract][Full Text] [Related]
19. Low-dose apatinib monotherapy in advanced chemotherapy-refractory small cell lung cancer: a case series and literature review.
Liu YY; Chen T; Shen D; Zhang WY; Wang CG; Jiang JH; Zeng DX
J Int Med Res; 2020 Mar; 48(3):300060519887276. PubMed ID: 31847652
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review.
Bi M; Yang J; Wang Y; Zhang H; Gao Z; Zhou H; Shi M
Onco Targets Ther; 2018; 11():883-890. PubMed ID: 29497319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
